Oxaliplatin Patent Expiration
Oxaliplatin is used for treating symptoms of depression, anxiety disorders, panic disorders, and certain types of pain. It was first introduced by Sanofi Aventis Us Llc
Oxaliplatin Patents
Given below is the list of patents protecting Oxaliplatin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Eloxatin |
US5420319 (Pediatric) | Cis-oxalato(trans-1-1,2-cyclohexanediamine) Pt(II) complex having high optical purity and process of preparing same |
Feb 09, 2017
(Expired) | Sanofi Aventis Us |
| Eloxatin | US5420319 | Cis-oxalato(trans-1-1,2-cyclohexanediamine) Pt(II) complex having high optical purity and process of preparing same |
Aug 09, 2016
(Expired) | Sanofi Aventis Us |
| Eloxatin |
US5716988 (Pediatric) | Pharmaceutically stable preparation of oxaliplatinum |
Feb 07, 2016
(Expired) | Sanofi Aventis Us |
| Eloxatin | US5716988 | Pharmaceutically stable preparation of oxaliplatinum |
Aug 07, 2015
(Expired) | Sanofi Aventis Us |
| Eloxatin |
US5338874 (Pediatric) | Cis oxalato (trans 1-1,2-cyclohexanediamine) PT(II) having optically high purity |
Oct 07, 2013
(Expired) | Sanofi Aventis Us |
| Eloxatin |
US5290961 (Pediatric) | Platinum compound and process of preparing same |
Jul 12, 2013
(Expired) | Sanofi Aventis Us |
| Eloxatin | US5338874 | Cis oxalato (trans 1-1,2-cyclohexanediamine) PT(II) having optically high purity |
Apr 07, 2013
(Expired) | Sanofi Aventis Us |
| Eloxatin | US5290961 | Platinum compound and process of preparing same |
Jan 12, 2013
(Expired) | Sanofi Aventis Us |
Oxaliplatin's Family Patents
Explore Our Curated Drug Screens
Oxaliplatin Generic API Manufacturers
Several generic applications have been filed for Oxaliplatin. The first generic version for Oxaliplatin was by Fresenius Kabi Oncology Plc and was approved on Aug 7, 2009. And the latest generic version is by Meitheal Pharmaceuticals Inc and was approved on Jan 11, 2024.
Given below is the list of companies who have filed for Oxaliplatin generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 3 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG/40ML (5MG/ML) | injectable | Discontinued | INTRAVENOUS | N/A | Mar 21, 2017 |
| 50MG/10ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Mar 21, 2017 |
| 100MG/20ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Mar 21, 2017 |
2. ACTAVIS
Actavis Llc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Actavis.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/10ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Mar 5, 2018 |
| 100MG/20ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Mar 5, 2018 |
Manufacturing Plant Locations New
Actavis's manufacturing plants are situated in 4 countries - Romania, United States, Italy, India. Given below are the details of these plant locations as well as the firm names of Actavis as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Romania |
| |||||||||||||||||||||||
| United States |
| |||||||||||||||||||||||
| Italy |
| |||||||||||||||||||||||
| India |
| |||||||||||||||||||||||
3. ACTAVIS TOTOWA
Actavis Totowa Llc has filed for 2 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Actavis Totowa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Aug 8, 2012 |
| 50MG/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Aug 8, 2012 |
Manufacturing Plant Locations New
Actavis Totowa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Totowa as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
4. AM REGENT
American Regent Inc has filed for 2 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Am Regent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/20ML (5MG/ML) | injectable | Discontinued | INTRAVENOUS | N/A | May 12, 2017 |
| 50MG/10ML (5MG/ML) | injectable | Discontinued | INTRAVENOUS | N/A | May 12, 2017 |
5. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 2 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/10ML (5MG/ML) | injectable | Discontinued | INTRAVENOUS | N/A | Feb 10, 2017 |
| 100MG/20ML (5MG/ML) | injectable | Discontinued | INTRAVENOUS | N/A | Feb 10, 2017 |
6. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 2 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/10ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Sep 6, 2017 |
| 100MG/20ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Sep 6, 2017 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
7. FRESENIUS KABI ONCOL
Fresenius Kabi Oncology Plc has filed for 2 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Oncol.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Aug 7, 2009 |
| 50MG/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Aug 7, 2009 |
Manufacturing Plant Locations New
Fresenius Kabi Oncol's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Oncol as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
8. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 5 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | injectable | Prescription | INTRAVENOUS | AP | Jun 2, 2010 |
| 50MG/VIAL | injectable | Prescription | INTRAVENOUS | AP | Jun 2, 2010 |
| 50MG/10ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Jan 31, 2017 |
| 100MG/20ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Jan 31, 2017 |
| 200MG/40ML (5MG/ML) | injectable | Discontinued | INTRAVENOUS | N/A | Jan 31, 2017 |
Manufacturing Plant Locations New
Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
9. GLAND
Gland Pharma Ltd has filed for 3 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Gland.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/20ML (5MG/ML)
(reference standard) | injectable | Prescription | INTRAVENOUS | AP | Feb 10, 2017 |
| 50MG/10ML (5MG/ML)
(reference standard) | injectable | Prescription | INTRAVENOUS | AP | Feb 10, 2017 |
| 200MG/40ML (5MG/ML) | injectable | Discontinued | INTRAVENOUS | N/A | Oct 18, 2017 |
Manufacturing Plant Locations New
Gland's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Gland as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
10. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 2 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/VIAL | injectable | Prescription | INTRAVENOUS | AP | May 23, 2017 |
| 100MG/VIAL | injectable | Prescription | INTRAVENOUS | AP | May 23, 2017 |
11. HENGRUI PHARMA
Jiangsu Hengrui Pharmaceuticals Co Ltd has filed for 2 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Hengrui Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/10ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Jun 18, 2014 |
| 100MG/20ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Jun 18, 2014 |
12. HOSPIRA INC
Hospira Inc has filed for 2 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Hospira Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Sep 30, 2009 |
| 50MG/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Sep 30, 2009 |
Manufacturing Plant Locations New
Hospira Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Hospira Inc as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
13. HOSPIRA WORLDWIDE
Hospira Worldwide Pty has filed for 2 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Hospira Worldwide.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/20ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Aug 7, 2009 |
| 50MG/10ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Aug 7, 2009 |
Manufacturing Plant Locations New
Hospira Worldwide's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Hospira Worldwide as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
14. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 2 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/10ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Jan 11, 2024 |
| 100MG/20ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Jan 11, 2024 |
15. MYLAN LABS LTD
Mylan Laboratories Ltd has filed for 3 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/10ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Aug 7, 2012 |
| 100MG/20ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Aug 7, 2012 |
| 200MG/40ML (5MG/ML) | injectable | Discontinued | INTRAVENOUS | N/A | Nov 14, 2017 |
16. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 2 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Aug 8, 2012 |
| 50MG/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Aug 8, 2012 |
17. NOVAST LABS
Novast Laboratories Ltd has filed for 2 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Novast Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/20ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Oct 16, 2018 |
| 50MG/10ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Oct 16, 2018 |
18. QILU PHARM HAINAN
Qilu Pharmaceutical Hainan Co Ltd has filed for 5 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Qilu Pharm Hainan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/VIAL | injectable | Prescription | INTRAVENOUS | AP | May 11, 2016 |
| 100MG/VIAL | injectable | Prescription | INTRAVENOUS | AP | May 11, 2016 |
| 50MG/10ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Jun 7, 2016 |
| 100MG/20ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Jun 7, 2016 |
| 200MG/40ML (5MG/ML)
(reference standard) | injectable | Prescription | INTRAVENOUS | N/A | Jun 7, 2016 |
19. SANDOZ
Sandoz Inc has filed for 4 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/20ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Jan 24, 2011 |
| 50MG/10ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Jan 24, 2011 |
| 50MG/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Apr 28, 2011 |
| 100MG/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Apr 28, 2011 |
Manufacturing Plant Locations New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| Austria |
| |||||
| United States |
| |||||
| Spain |
| |||||
| India |
| |||||
20. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 5 different strengths of generic version for Oxaliplatin. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Aug 7, 2009 |
| 100MG/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Aug 7, 2009 |
| 100MG/20ML (5MG/ML) | injectable | Discontinued | INTRAVENOUS | N/A | Apr 8, 2014 |
| 50MG/10ML (5MG/ML) | injectable | Discontinued | INTRAVENOUS | N/A | Apr 8, 2014 |
| 200MG/40ML (5MG/ML) | injectable | Discontinued | INTRAVENOUS | N/A | Feb 15, 2019 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||